Increased megalin expression in early type 2 diabetes: role of insulin-signaling pathways

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1191-F1207. doi: 10.1152/ajprenal.00210.2018. Epub 2018 Jun 27.

Abstract

The megalin/cubilin complex is responsible for the majority of serum protein reclamation in the proximal tubules. The current study examined if decreases in their renal expression, along with the albumin recycling protein neonatal Fc receptor (FcRn) could account for proteinuria/albuminuria in the Zucker diabetic fatty rat model of type 2 diabetes. Immunoblots of renal cortex samples obtained at worsening disease stages demonstrated no loss in megalin, cubilin, or FcRn, even when proteinuria was measured. Additionally, early diabetic rats exhibited significantly increased renal megalin expression when compared with controls (adjusted P < 0.01). Based on these results, the ability of insulin to increase megalin was examined in a clonal subpopulation of the opossum kidney proximal tubule cell line. Insulin treatments (24 h, 100 nM) under high glucose conditions significantly increased megalin protein ( P < 0.0001), mRNA ( P < 0.0001), and albumin endocytosis. The effect on megalin expression was prevented with inhibitors against key effectors of insulin intracellular signaling, phosphatidylinositide 3-kinase and Akt. Studies using rapamycin to inhibit the mechanistic target of rapamycin complex 1 (mTORC1) resulted in a loss of insulin-induced megalin expression. However, subsequent evaluation demonstrated these effects were independent of initial mTORC1 suppression. The presented results provide insight into the expression of megalin, cubilin, and FcRn in type 2 diabetes, which may be impacted by elevated insulin and glucose. Furthermore, proximal tubule endocytic activity in early diabetics may be enhanced, a process that could have a significant role in proteinuria-induced renal damage.

Keywords: cubilin; diabetic nephropathy; megalin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria / etiology
  • Albuminuria / genetics
  • Albuminuria / metabolism*
  • Albuminuria / physiopathology
  • Animals
  • Blood Glucose / metabolism*
  • Cells, Cultured
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / metabolism*
  • Diabetic Nephropathies / physiopathology
  • Disease Models, Animal
  • Disease Progression
  • Endocytosis / drug effects
  • Glycogen Synthase Kinase 3 / metabolism
  • Histocompatibility Antigens Class I / metabolism
  • Insulin / pharmacology*
  • Kidney Tubules, Proximal / drug effects*
  • Kidney Tubules, Proximal / metabolism*
  • Kidney Tubules, Proximal / physiopathology
  • Low Density Lipoprotein Receptor-Related Protein-2 / genetics
  • Low Density Lipoprotein Receptor-Related Protein-2 / metabolism*
  • Male
  • Mechanistic Target of Rapamycin Complex 2 / metabolism
  • Opossums
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats, Zucker
  • Receptors, Cell Surface / metabolism
  • Receptors, Fc / metabolism
  • Signal Transduction / drug effects
  • Time Factors
  • Up-Regulation

Substances

  • Blood Glucose
  • Histocompatibility Antigens Class I
  • Insulin
  • Low Density Lipoprotein Receptor-Related Protein-2
  • Lrp2 protein, rat
  • Receptors, Cell Surface
  • Receptors, Fc
  • intrinsic factor-cobalamin receptor
  • Phosphatidylinositol 3-Kinases
  • Mechanistic Target of Rapamycin Complex 2
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
  • Fc receptor, neonatal